Literature DB >> 3048002

Immunohistochemical study of medullary thyroid carcinoma: relationship of clinical features to prognostic factors in 36 patients.

H Takami, T Bessho, T Kameya, T Mimura, K Ito, O Abe, Y Hosoda, J Shikata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3048002     DOI： 10.1007/BF01655455

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  28 in total

1.  Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma.

Authors:  R A DeLellis; A H Rule; I Spiler; L Nathanson; A H Tashjian; H J Wolfe
Journal:  Am J Clin Pathol       Date:  1978-10       Impact factor: 2.493

2.  Differential expression of the human calcitonin--CGRP gene in medullary thyroid carcinoma and lung carcinoma cell lines.

Authors:  R K Craig; M R Edbrooke; J H Riley; J H McVey; D Parker
Journal:  Recent Results Cancer Res       Date:  1985

3.  Regulation of neuroendocrine gene expression by alternative RNA processing. Colocalization of calcitonin and calcitonin gene-related peptide in thyroid C-cells.

Authors:  M I Sabate; L S Stolarsky; J M Polak; S R Bloom; I M Varndell; M A Ghatei; R M Evans; M G Rosenfeld
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

4.  Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.

Authors:  M F Saad; H A Fritsche; N A Samaan
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

5.  Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma.

Authors:  A Miyauchi; T Onishi; S Morimoto; S Takai; F Matsuzuka; K Kuma; M Maeda; Y Kumahara
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

6.  Structure and expression of a gene encoding human calcitonin and calcitonin gene related peptide.

Authors:  B D Nelkin; K I Rosenfeld; A de Bustros; S S Leong; B A Roos; S B Baylin
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

7.  The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase.

Authors:  S M Lippman; G Mendelsohn; D L Trump; S A Wells; S B Baylin
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

8.  Immunocytochemical localisation of katacalcin, a calcium-lowering hormone cleaved from the human calcitonin precursor.

Authors:  A Ali-Rachedi; I M Varndell; P Facer; C J Hillyard; R K Craig; I MacIntyre; J M Polak
Journal:  J Clin Endocrinol Metab       Date:  1983-09       Impact factor: 5.958

9.  Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues.

Authors:  D T O'Connor; D Burton; L J Deftos
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

10.  Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study.

Authors:  G Mendelsohn; S B Baylin; S H Bigner; S A Wells; J C Eggleston
Journal:  Am J Surg Pathol       Date:  1980-08       Impact factor: 6.394
View more
  3 in total

Review 1.  Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

Authors:  Ying-Hsia Chu; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

Review 2.  Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.

Authors:  Hiroshi Takami
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

3.  [Progress in the diagnosis and therapy of C cell carcinoma of the thyroid gland].

Authors:  A Frilling; P E Goretzki; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1990
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.